HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guja Astrea Selected Research

Guanosine Diphosphate Mannose (GDP Mannose)

1/2018Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study.
1/2018Mutations in GMPPB Presenting with Pseudometabolic Myopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guja Astrea Research Topics

Disease

7Muscular Diseases (Myopathy)
01/2022 - 01/2013
4Muscular Dystrophies (Muscular Dystrophy)
01/2018 - 03/2014
2Disease Progression
01/2022 - 12/2021
2Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
03/2019 - 01/2018
2Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2018 - 10/2016
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
10/2016 - 07/2012
1Central Core Myopathy (Central Core Disease)
01/2022
1Minicore Myopathy with External Ophthalmoplegia
01/2022
1COVID-19
12/2021
1Neuromuscular Diseases (Neuromuscular Disease)
06/2020
1Inborn Genetic Diseases (Disease, Hereditary)
03/2019
1Walker-Warburg Syndrome
01/2018
1Myotonic Dystrophy (Dystrophia Myotonica)
10/2016
1Cognitive Dysfunction
01/2016
1Congenital myasthenic syndrome with episodic apnea
01/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016
1Hypogonadism (Hypergonadotropic Hypogonadism)
07/2015
1Intellectual Disability (Idiocy)
03/2014
1Group II Malformations of Cortical Development
03/2014
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
03/2014
1Neutral Lipid Storage Disease with Myopathy
01/2013
1Vocal Cord Paralysis
08/2012
1Down Syndrome (Down's Syndrome)
09/2007

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
03/2019 - 08/2012
3Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2022 - 05/2015
3Dystroglycans (Dystroglycan)IBA
01/2018 - 01/2016
2mannose 1-phosphate guanylyltransferaseIBA
01/2018 - 01/2018
2Guanosine Diphosphate Mannose (GDP Mannose)IBA
01/2018 - 01/2018
1EnzymesIBA
01/2018
1Muscle Proteins (Muscle Protein)IBA
10/2016
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
03/2016
1choline transporterIBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
01/2016
1Cholinergic Agents (Cholinergics)IBA
01/2016
1Growth Hormone (Somatotropin)IBA
07/2015
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2014
1Cytoplasmic DyneinsIBA
03/2014
1Dyneins (Dynein)IBA
03/2014
1Lipase (Acid Lipase)FDA Link
01/2013
1LipidsIBA
01/2013
1OsteopontinIBA
07/2012
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
09/2007
1Folic Acid (Vitamin M)FDA LinkGeneric
09/2007
1HomocysteineIBA
09/2007
1Reduced Folate Carrier ProteinIBA
09/2007

Therapy/Procedure

3Therapeutics
12/2021 - 01/2017
1Continuity of Patient Care
12/2021